Ohio is on the verge of rewriting the rules for marijuana and driving, with Senate Bill 55 now parked in the House Judiciary Committee after clearing the Senate. The measure, which the Ohio Senate approved Oct. 8, 2025, would move the state away from prosecuting drivers based on marijuana metabolites that can linger in the body and toward tests focused on active THC. It would also tweak the numerical thresholds that trigger an OVI charge. Supporters say this will stop people from getting tagged for cannabis use days or weeks in the past. Critics worry it could make it tougher to nail dangerously high drivers at the roadside.
What SB 55 Would Actually Do
Under the substitute version adopted in the Senate, SB 55 would scrap metabolite-based prohibitions, raise the whole-blood per se THC threshold from two to five nanograms per milliliter, and streamline several marijuana-specific OVI offenses into a smaller group of charges. The bill would also add limited evidentiary inferences for certain low THC levels and would spell out that defendants can challenge the testing method, process and equipment at both the pretrial and trial stages, according to the Ohio Legislature. The drafters say they are trying to line up criminal proof with current science while still giving police tools to pull visibly impaired drivers off the road.
Supporters Say It Fixes Lopsided Outcomes
Defense attorneys and civil-liberties advocates told the House Judiciary Committee that the current regime can convict drivers who are no longer impaired, since metabolites can be detectable long after any high has faded. As reported by Scioto Valley Guardian, Columbus attorney Bryan Hawkins called it "patently unfair" to convict someone based solely on an inactive metabolite. Backers argue SB 55 respects voter-approved legalization while still letting officers act when a driver is clearly impaired.
Safety Stats And Skeptics
Opponents and some safety advocates counter that there is no single THC number that reliably matches impairment for every driver and every situation, and they warn that loosening the per se standards could mean fewer convictions for people who were actually high behind the wheel. Their concerns are playing out against recent data presented at the American College of Surgeons, which found that 41.9% of drivers killed in Montgomery County crashes tested positive for active THC, according to the American College of Surgeons. Policy analysts at OSU’s Moritz College of Law note that while metabolite-based convictions are scientifically shaky, per se THC limits are still hotly debated and could drag courts into more complicated toxicology fights.
How The Courtroom Could Change
SB 55 is not just a wording cleanup. It would reshape how OVI cases play out in court by explicitly inviting defense lawyers to attack "the method, process, reliability, or equipment" used for blood, urine and oral-fluid testing, a shift that could mean more pretrial motions and evidentiary hearings. Prosecutors argue the bill still leaves them ways to charge drivers who show clear signs of impairment, while defense attorneys say those added procedural protections are necessary to avoid convictions that rest only on residual chemicals, as reported by Scioto Valley Guardian. Judges’ rulings on what testing evidence gets in and how reliable it is will ultimately decide how strict or flexible the new rules feel on the ground.
What Happens Next At The Statehouse
For now, SB 55 sits in the House Judiciary Committee and still needs a full House vote plus the governor’s signature before it becomes law. No date has been set for a floor vote. The Ohio Senate backed the bill 28–0 on Oct. 8, 2025, according to the voting record from the Ohio Legislature. Lawmakers on the House committee are expected to be the main players in working out technical tweaks to testing technology rules and the bill’s evidentiary inference language.
Why It Matters On Ohio Roads
SB 55 is shaping up as a test case for how states try to balance legalized cannabis with road safety and fair prosecutions. The bill trades an older system that leans on lingering metabolites for a framework centered on active THC, but it leaves plenty of open questions about toxicology, enforcement and how science-heavy these trials might become. As the House process unfolds, lawmakers, courts and advocacy groups will be watching closely to see whether the final version tilts more toward public safety, defendants’ rights or some uneasy middle ground.
